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Abstract 
Background: To study trends in levels of lipids in 
prehypertensive and normotensive people. 
Methods: In this cross sectional study a total of 90 
apparently healthy subjects with age being 30-59 
years and without any other illness were selected. 
Blood pressure was monitored and categorised into 
normotensive group 1 (n-39) and prehypertensive 
group 2 (n=39). Any volunteer with raised blood 
sugar was excluded from the study. Their blood was 
collected and sera was seperated after 
ultracentrifugation to analyze triglycerides, total 
cholesterol, LDL and HDL. Independent student t-
test (2-tailed) was applied in order to compare 
difference between selected variables such as age, 
BMI, total cholesterol, LDL, HDL and triglycerides 
of normotensives and prehypertensive groups. 
Results: Mean values of serum cholesterol, serum 
LDL, serum HDL and serum triglycerides were 
higher in prehypertensives than normotensives. 
Serum HDL was found to be relatively low in all 
subjects regardless of their blood pressure levels. No 
difference in demographic variables were found 
amongst two groups and were found within range. 
Conclusion: Mean serum lipids were found to be 
raised in prehypertensives than normotensives but 
difference was statistically insignificant.Frequencies 
and percentages of serum lipids were higher in 
prehypertensives than normotensives but difference 
was statistically insignificant. 
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Introduction 
    Hypertension is defined as persistent elevations of 
systolic blood pressure at or above 140 mmHg and 
diastolic blood pressure at or  above 90 mmHg.1   
Prehypertension is defined as higher than normal 
blood pressure in which readings for systolic and 
diastolic blood pressure are below baseline values for 
hypertension. 2 The seventh report of the joint National 
Committee for the detection, evaluation and treatment 
of high blood pressure (JNC-7) published in 2003 
proposed new guidelines in which a person having 
systolic blood pressure ranging from 120 mmHg to 139 
mmHg and diastolic blood pressure ranging  from 80 
to 89 mmHg will be considered as prehypertensive. 2   
     Prehypertension is an insidious disease and may go 
unnoticed for many years till state of full blown 
hypertension is achieved. State of prehypertension in 
clinical settings is usually an incidental finding .There 
are no specific signs and symptoms associated with 
prehypertensive state. State of prehypertension and its 
hazardous effects   along with its treatment still remain 
controversial. Most studies have clearly demonstrated 
prehypertensive state to be as fatal as hypertensive 
state. 3  Prehypertension is strongly linked with heart 
diseases, stroke and nephropathy as reported in 
several clinical studies.4, 5 Population having 
prehypertension for extended period of time are at 
increased risk for developing malignant hypertension 
in future.6, 7  
    Sedentary lifestyle, higher body mass index( BMI ) 
and increased dietary sodium can contribute to rise in 
blood pressure by middle age of  adolescence if their 
values stay around cutoff point for 
prehypertension(120/80 mm Hg).  8, 9  National high 
blood pressure  education program working group 
presented a fourth report on high blood pressure in 
adolescents and children which introduced the 
varying effects of prehypertension  leading to 
increased risk of  progression of  chronic kidney 
disease and cardiovascular risk factors.2    
Prehypertensive and hypertensive people have usually 
low arterial compliance  which is due to the action of 
aldosterone on smooth walls of vessels and 
potentiating total peripheral resistance.10  Free fatty 
acids in the blood result in increased levels of cortisol 
via neuroendocrine reflex which results in increased 
production of angiotensinogen by the hepatocytes and 
enhancing vascular endothelial reactivity.11 
Prehypertensive  Pakistani  population  had higher  
circulating blood levels of various stress hormones 
namely  cortisol and  aldosterone which are 
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attributable to stressful life at a younger age which 
may develop into full blown hypertension.12  
   Dyslipidaemia is defined as deranged amount of 
blood lipids. Lipids such as cholesterol could be in 
either low or high amounts. Hyperlipdaemia is 
defined as increased levels of lipids in the blood.13 14  
Levels of blood lipids may depend on phenotype or 
etiological factors such as interplay of genetics and 
mode of living like a sedentary one may play roles in 
deranging lipid profile.Prehypertension has been 
linked to the development of cardiometabolic 
disorders such as derangement of lipid profile thereby 
increasing incidence of heart diseases and various 
other problems.  Relatively higher levels of  
triglycerides and LDL were detected in Indian, 
Chinese and Malay population without diabetes 
mellitus or hypertension but having prehypertension 
over a long period of time. 15  
  Studies conducted in western world have also shown 
prehypertension as a risk factor for the development of 
 deranged lipid profile. One of the analysis was done 
on healthy volunteers who took part in NHANES from 
1999 to 2006 which revealed that prevalence of 
prehypertension and other metabolic disorders such as 
deranged lipids was at 36.3% (p<0.001).16, 17 High LDL 
can lead to failure of endothelial relaxation of blood 
vessels thereby leading to state of subnormal blood 
pressure.18 A strong correlation was found amongst 
hypertension and raised lipids especially serum low 
density lipoproteins.19 Similarly, serum LDL, total 
cholesterol, triglycerides were found to be higher in  
young subjects having subnormal blood pressure and 
full blown hypertension along with a complex 
interplay of their BMI in a study done in US in 8th 
grade adolescents. 20  However, mean lipid levels in 
US population were found to be higher in females than 
men and their levels varied from ethnicities to their 
area of living and diet. 21 Risk for endothelial damage 
increases by atherogenic deposition of plaque in 
coronary vessels due to raised lipid during 
prehypertension. 22  
 
Patients and Methods 
This cross sectional study was conducted at 
Centre for Research in Experimental and Applied 
Medicine (CREAM), and Armed Forces Institute of 
Pathology (AFIP), Army Medical College, Rawalpindi, 
National University of Science and Technology 
(NUST), Pakistan from Jan 2013 to Feb 2014. Approval 
from ethical committee of Army Medical College, 
National University of Sciences and Technology 
(NUST) was obtained before undertaking the research 
project. The study was conducted in accordance with 
the current Good Clinical Practices and the Declaration 
of Helsinki. A total of 90  apparently healthy subjects 
with age being 30-59 years and without any other 
illness were selected. Their blood pressure was 
monitored and categorised into normotensive group 1 
(n-39)and prehypertensive group 2 (n=39). Any 
volunteer with raised blood sugar was excluded from 
the study. Their blood was collected and sera was 
separated after ultracentrifugation. Analysis of 
triglycerides, total cholesterol, LDL and HDL was 
done. Independent student t-test (2-tailed) was applied 
in order to compare difference between selected 
variables such as age, BMI, total cholesterol, LDL, 




     A total of 78 subjects were selected and their 
demographic variables such as age and BMI revealed 
no statistical difference (p>0.05). Total cholesterol was 
164.74±32.52 mg/dl in normotensive group and 
179.95±37.86 mg/dl in prehypertensive group with 
p>0.05. Serum triglycerides were 184.16±105.71 mg/dl 
in normotensive group and 209.18±102.16 mg/dl in 
prehypertensive group (p>0.05). Serum  LDL was 
92.44±24.89 mg/dl in normotensives whereas 
prehypertensives had slightly raised LDL values but 
difference was found to statistically not that 
significant.Similarly,serum HDL levels were 
38.83±6.44 mg/dl and 41.04±7.77 mg/dl in both 
groups (p>0.05)(Table 1).  Total cholesterol above its 
cutoff value was found in 5 normotensive  and  30  
prehypertensive individuals. Percentages above cutoff 
levels of total cholesterol were 12.8% in normotensives 
and 76.9% in prehypertensives respectively. However, 
desirable levels of total cholesterol below their cutoff 
levels of  200mg/dl were found in 34 normotensives 
and 9 prehypertensives. Percentages for desirable 
cholesterol levels were 87% and 23.1% in 
normotensive and prehypertensive groups 
respectively.Low density lipoproteins more than its 
cutoff levels were in 2 normotensives and 1 
prehypertensives with precentages of 5.1% and 2.6% 
respectively. Similarly, LDL within acceptable levels 
i.e; below their cutoff values were present in 37 
normotensives with a 94.9% and 38 prehypertensives 
with  97.4% (Table 2).Nine normotensives and 25 
prehypertensives had cutoff  values of triglycerides 
above 236mg/dl. Percentages were found to be 23.1% 
and 64.1% in  normotensives and prehypertensives 
respectively. Triglycerides within desirable levels were 
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present in 30 normotensives and 14 prehypertensives 
with desirables percentages as 76.9% and 35.9% 
respectively. Desirable HDL levels were actually set 
above cutoff level of 45 mg/dl and were found in only 
6 normotensive subjects and 26 prehypertensive 
subjects whereas percentages for normotensives and 
prehypertensives were 15.4% and 66.7% respectively. 
HDL below cutoff value  were present in 33 
normotensive subjects and 10 prehypertensive subjects 
with percentages of  84.6% and 25.6% 
respectively(Table 2). 
Table 1:  Comparison of age, BMI, SBP, DBP 
and serum lipid profile between normotensive 
and prehypertensive groups 
Parameters 
 




Age in Yrs 38.74± 5.71 38.07± 3.84 0.547 
BMI (Kg/m2) 24.67±2.30 25.20±2.27 0.305 
Cholesterol 
(mg/dl) 






LDL(mg/dl) 92.44±24.89 98.43±21.05 0.254 
HDL(mg/dl) 38.83±6.44 41.04±7.77 0.176 
Recommended range (NCEP Coordinating Committee): Total 
Cholesterol< 200mg,  LDL< 130 mg/dl,  Triglycerides <236 
mg/dl,   HDL>45mg/dl 
Table 2: Serum lipids above and below cutoff 
levels  in prehypertensive and normotensive 
subjects 
Variables Levels of 
lipids 
CVS Risk   
status 
          Normotensives Prehypertensives 
Frequency Percentage Frequency Percent
age 
   Total 
Cholesterol 
(mg/dl) 
>200mg/dl  High        5    12.8%        30    76.9% 
< 200mg/dl Desirable       34    87%         9     
23.1% 
LDL(mg/dl) >130 mg/dl 
 
   High        2    5.1%     1     2.6% 
<130 mg/dl Desirable       37    94.9%      38    97.4% 
Triglyceride 
(mg/dl) 
>236 mg/dl High        9 23.1%      25    64.1% 
<236 mg/dl Desirable       30 76.9%      14    35.9% 
HDL(mg/dl) <45 mg/dl Low       33    84.6%      10    25.6% 
>45 mg/dl Desirable       6    15.4%      26     
66.7% 
Recommended range (NCEP  Coordinating Committee) :Total 
Cholesterol< 200mg,LDL< 130 mg/dl, Triglycerides <236 mg/dl,  
 HDL>45mg   
 
Discussion 
     Present study conducted in prehypertensive and 
control groups showed no statistical differences. 
However, levels of serum lipids were relatively higher 
in prehypertensive group compared to control group. 
Contrary to the present study, association was found 
between prehypertension and dyslipidaemia in a cross 
sectional study done on 767 healthy military 
personnel. However multivariate logistic regression 
analysis showed positive association with body mass 
index and age as well. 23,24  
    It has been already known that essential 
hypertension is associated with metabolic syndrome. 
However its link to the state of prehypertension has 
not been established. Increase in blood lipids such as 
total cholesterol and triglycerides were noted with 
gradual increase in systolic and diastolic blood 
pressures in a community based cohort study. 
Moreover, a fall in high density lipoproteins was noted 
as well . Other parameters which were found to be 
raised were high blood glucose levels thereby 
indicating increase in insulin resistance and and an 
increase in accumulation of fat tissue.25, 26  
    In Mongolian and Han people good correlation was 
found between prehypertension and raised serum 
lipids and BMI along with age and smoking.27A 
population based study was done in Utah in which all 
subjects were having elevated blood pressure levels 
and a strong association was found between 
hypertension and elevated levels of serum cholesterol, 
serum triglycerides, serum LDL and HDL. However, 
this study also  included siblings of same parent so 
chances of familial dyslipidaemia must be taken into 
account. Deranged serum lipids can be due to the 
complex interplay of  elevated blood pressure levels 
and might be due to  hereditary factors. 28  
    Owing to the strong link between hypertension and 
dyslipidaemia, lifestyle modifications and  several 
drug regimens have been proposed by JNC-7 and 
third report of  NCEP in order  to curb cardiovascular 
diseases.29  Dyslipidaemia can itself be strong 
predictor of future development of prehypertension 
and hypertension. Physician health study revealed that 
healthy volunteers in the highest quantities of total 
cholesterol were more likely to suffer from elevated 
blood pressure levels than those subjects whose total 
cholesterol remained within lowest quintile. 30  
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